Two Sigma Securities’s Nexalin Technology NXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,712
Closed -$16K 2032
2025
Q4
$16K Buy
+28,712
New +$32.3K ﹤0.01% 1210
2025
Q3
Sell
-11,767
Closed -$11.6K 1836
2025
Q2
$11.6K Buy
+11,767
New +$16.5K ﹤0.01% 1289
2024
Q4
Sell
-23,045
Closed -$15.4K 2731
2024
Q3
$15.4K Buy
+23,045
New +$23.7K ﹤0.01% 2537
2023
Q2
Sell
-28,679
Closed -$22.9K 3175
2023
Q1
$22.9K Buy
+28,679
New +$28.4K ﹤0.01% 2346

Other funds holding NXL

Two Sigma Securities's NXL Position: Q1 2026 in Review

Two Sigma Securities sold out of Nexalin Technology (NXL) in Q1 2026, closing a stake of 28,712 shares — an estimated $16K sold.

Two Sigma Securities first reported a position in NXL in Q1 2023 and held it in 4 quarters. The position peaked at $22.9K in Q1 2023. 23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

  • Two Sigma Securities reported no remaining Nexalin Technology position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 28,712 Nexalin Technology shares in Q1 2026, an estimated $16K.
  • Two Sigma Securities first reported a position in Nexalin Technology in Q1 2023 and held it in 4 quarters.
  • Two Sigma Securities's Nexalin Technology position peaked at $22.9K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.